Jiří Špaček

Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial

Amit M. Oza, David Cibula, Ana Oaknin Benzaquen et al. · The Lancet Oncology · 2014 · 540 citations

Medicine, Randomised Phase 2, Gynecology +6

Antibiotic administration reduces the rate of intraamniotic inflammation in preterm prelabor rupture of the membranes

Marián Kacerovský, Roberto Romero, Martin Štěpán et al. · American Journal of Obstetrics and Gynecology · 2020 · 97 citations · Full text

Inflammation, Antibiotic Administration, Antimicrobial Susceptibility +10

Olaparib plus paclitaxel plus carboplatin (P/C) followed by olaparib maintenance treatment in patients (pts) with platinum-sensitive recurrent serous ovarian cancer (PSR SOC): A randomized, open-label phase II study.

Amit M. Oza, David Cibula, Ana Oaknin et al. · Journal of Clinical Oncology · 2012 · 67 citations

Gynecology, Pharmacotherapy, Gynecology Oncology +16

Methylation in the p53 promoter in epithelial ovarian cancer

Marcela Chmelařová, E Křepinská, Jiří Špaček et al. · Clinical & Translational Oncology · 2012 · 64 citations

Epigenetic Change, P53 Promoter, Epigenomics +6

A Comparison of Dequalinium Chloride Vaginal Tablets (Fluomizin®) and Clindamycin Vaginal Cream in the Treatment of Bacterial Vaginosis: A Single-Blind, Randomized Clinical Trial of Efficacy and Safety

E. R. Weissenbacher, Gilbert Donders, Vít Unzeitig et al. · Gynecologic and Obstetric Investigation · 2011 · 62 citations · Full text